Clinical trialNCT05500807RecruitingPhase 1Interventional

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

SponsorBleeding and Clotting Disorders Institute Peoria, IllinoisEnrollment40Concomitant VWD and HemophiliaVon Willebrand Disease, Type 3

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jonathan C Roberts, MD
Bleeding and Clotting Disorders Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

the Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (cibd)
Orange, California, United States
Vanessa Salinas, MD
Recruiting
Stanford University: Stanford Children'S Health
Redwood City, California, United States
May Chien, MD
Recruiting
University of Miami - Miller School of Medicine
Coral Gables, Florida, United States
Fernando Francisco Corrales-Medina, MD
Recruiting
St. Joseph'S Children'S Hospital - Center for Bleeding and Clotting Disorders
Tampa, Florida, United States
Erin M Cockrell, DO
Recruiting
Bleeding and Clotting Disorders Institute (bcdi)
Peoria, Illinois, United States
Jonathan C Roberts, MDMichael D Tarantino, MD
Recruiting
Innovative Hematology, Inc. (ihi)
Indianapolis, Indiana, United States
Sweta L Gupta, MD
Recruiting
University of Michigan Medical School
Ann Arbor, Michigan, United States
Angela Weyand, MD
Recruiting
Central Michigan University: Children'S Hospital of Michigan
Mount Pleasant, Michigan, United States
Meera Chitlur, MD
Recruiting
Children'S Mercy Hospital
Kansas City, Missouri, United States
Shannon L Carpenter, MD
Recruiting
Penn State College of Medicine
Hershey, Pennsylvania, United States
Huseyin Erdemir, MD
Recruiting
Washington Center for Bleeding Disorders
Seattle, Washington, United States
Rebecca Kruse-Jarres, MD, MPH
Recruiting
Uw Health Comprehensive Program for Bleeding Disorders
Madison, Wisconsin, United States
John Sheehan, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Nov 2022
Primary completion: 30 Jun 2027
Completion: 29 Feb 2028
Last update posted: 3 Apr 2026
Registered enrollment: 40
Registry id: NCT05500807

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.